Catalyst Wire Dossier Catalyst Wire Dossier

NEREUS

Tradipitant · Vanda Pharmaceuticals Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NEREUS, covering 2025-12-30 to 2025-12-30. Get the full timeline:

Most recent: FDA Approved: NEREUS — Original Application (Vanda Pharmaceuticals Inc.)

See pricing